Apple, Microsoft, Meta To Report Results; Fed's Interest Rate Decision In Focus
Source: SeekingAlpha
2026-01-24 11:00:00 ET
Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports, and conference presentations....
Read the full article on Seeking Alpha
For further details see:
Apple, Microsoft, Meta To Report Results; Fed's Interest Rate Decision In Focus
ImmunityBio Inc.
NASDAQ: IBRX
IBRX Trading
7.37% G/L:
$8.5414 Last:
17,220,926 Volume:
$8.21 Open:
IBRX Latest News
March 13, 2026 07:30:00 am
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
March 09, 2026 07:30:00 am
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
March 05, 2026 10:20:00 am
Forget ImmunityBio: This Big?Cap Pharma Is the Safer Play on Next?Gen Cancer Therapies
February 27, 2026 07:30:00 am
ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026
IBRX Stock Data
$6,497,322,803
300,611,373
0.32%
122
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
